Gilmore O’Neill

CEO

CEO Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Editas Medicine, Inc. (EDIT)	M.B., M.M.Sc. President and Chief Executive Officer	$686,574	—	—	$1,282,937	$375,164	$8,980	$2,353,655
2024	Editas Medicine, Inc. (EDIT)	M.B., M.M.Sc. President and Chief Executive Officer	$667,100	—	$1,296,544	$2,714,038	$440,286	$8,900	$5,126,868
2023	Editas Medicine, Inc. (EDIT)	M.B., M.M.Sc. President and Chief Executive Officer	$641,092	—	$436,000	$915,390	$392,537	$7,290	$2,392,309
2022	Editas Medicine, Inc. (EDIT)	M.B., M.M.Sc. President and Chief Executive Officer	$355,769	—	$999,999	$7,495,059	$201,329	$6,744	$9,058,900
2020	Sarepta Therapeutics, Inc. (SRPT)	M.B., M.M.Sc. Executive Vice President, Chief Medical Officer ^^	$599,795	—	$1,745,044	$4,309,949	$301,959	$619,276	$7,576,022
2019	Sarepta Therapeutics, Inc. (SRPT)	M.B., M.M.Sc. Executive Vice President, Chief Medical Officer ^^	$583,277	—	$766,949	$2,131,159	$293,164	$15,500	$3,790,049
2018	Sarepta Therapeutics, Inc. (SRPT)	M.B., M.M.Sc. Executive Vice President, Chief Medical Officer ^^	$563,962	—	—	$4,234,786	$354,063	$15,300	$5,168,110
2017	Sarepta Therapeutics, Inc. (SRPT)	M.B., M.M.Sc. Executive Vice President, Chief Scientific Officer ^^	—	—	—	—	—	—	—

Earnings-call appearances

2026 Jefferies Global Healthcare Conference
Editas Medicine, Inc. (EDIT)

2026-06-04
Barclays 28th Annual Global Healthcare Conference
Editas Medicine, Inc. (EDIT)

2026-03-12
Editas Medicine, Inc. Q2 FY2024 Earnings Call
Editas Medicine, Inc. (EDIT)

2024-08-07
Editas Medicine, Inc. Q1 FY2024 Earnings Call
Editas Medicine, Inc. (EDIT)

2024-05-08
Editas Medicine, Inc. Q4 FY2023 Earnings Call
Editas Medicine, Inc. (EDIT)

2024-02-28
Editas Medicine, Inc. Q3 FY2023 Earnings Call
Editas Medicine, Inc. (EDIT)

2023-11-03
Editas Medicine, Inc. Q2 FY2023 Earnings Call
Editas Medicine, Inc. (EDIT)

2023-08-02
Editas Medicine, Inc. Q1 FY2023 Earnings Call
Editas Medicine, Inc. (EDIT)

2023-05-05
Editas Medicine, Inc. Q4 FY2022 Earnings Call
Editas Medicine, Inc. (EDIT)

2023-02-22
Editas Medicine, Inc. Q3 FY2022 Earnings Call
Editas Medicine, Inc. (EDIT)

2022-11-02
Editas Medicine, Inc. Q2 FY2022 Earnings Call
Editas Medicine, Inc. (EDIT)

2022-08-03
Sarepta Therapeutics, Inc. Q3 FY2021 Earnings Call
Sarepta Therapeutics, Inc. (SRPT)

2021-10-15
Sarepta Therapeutics, Inc. Q2 FY2021 Earnings Call
Sarepta Therapeutics, Inc. (SRPT)

2021-06-30
Sarepta Therapeutics, Inc. Q1 FY2021 Earnings Call
Sarepta Therapeutics, Inc. (SRPT)

2021-03-31
Sarepta Therapeutics, Inc. Q4 FY2020 Earnings Call
Sarepta Therapeutics, Inc. (SRPT)

2021-01-11
Sarepta Therapeutics, Inc. Q3 FY2020 Earnings Call
Sarepta Therapeutics, Inc. (SRPT)

2020-09-30
Sarepta Therapeutics, Inc. Q2 FY2020 Earnings Call
Sarepta Therapeutics, Inc. (SRPT)

2020-06-30
Sarepta Therapeutics, Inc. Q1 FY2020 Earnings Call
Sarepta Therapeutics, Inc. (SRPT)

2020-03-31